# Oral Administration or Nasal Feeding of Huzhangxiefei Decoction for Treatment in Sepsis Induced Acute Lung Injury

> **NCT04940676** · PHASE2 · UNKNOWN · sponsor: **Xinhua Hospital, Shanghai Jiao Tong University School of Medicine** · enrollment: 58 (estimated)

## Conditions studied

- Acute Lung Injury
- Sepsis

## Interventions

- **DRUG:** Huzhangxiefei Decoction
- **DRUG:** 10% Huzhangxiefei Decoction

## Key facts

- **NCT ID:** NCT04940676
- **Lead sponsor:** Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-03-10
- **Primary completion:** 2022-11-30
- **Final completion:** 2022-12-31
- **Target enrollment:** 58 (ESTIMATED)
- **Last updated:** 2021-11-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04940676

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04940676, "Oral Administration or Nasal Feeding of Huzhangxiefei Decoction for Treatment in Sepsis Induced Acute Lung Injury". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT04940676. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*